相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen
Claudia D. Wurster et al.
JOURNAL OF NEUROLOGY (2020)
Serial measurement of S100B and NSE in pediatric traumatic brain injury
Dae-Won Park et al.
CHILDS NERVOUS SYSTEM (2019)
The S100B story: from biomarker to active factor in neural injury
Fabrizio Michetti et al.
JOURNAL OF NEUROCHEMISTRY (2019)
NFL is a marker of treatment response in children with SMA treated with nusinersen
Bob Olsson et al.
JOURNAL OF NEUROLOGY (2019)
Neurofilament as a potential biomarker for spinal muscular atrophy
Basil T. Darras et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment
Claudia D. Wurster et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
Maxim De Schaepdryver et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
Monique Sieber et al.
JOURNAL OF FORENSIC AND LEGAL MEDICINE (2018)
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis
Antonio Scarafino et al.
JOURNAL OF NEUROLOGY (2018)
Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
Gene L. Bowman et al.
ALZHEIMERS & DEMENTIA (2018)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers
Richard Rubenstein et al.
JAMA NEUROLOGY (2017)
Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain injury Dynamics: A Systematic Review
Eric Peter Thelin et al.
FRONTIERS IN NEUROLOGY (2017)
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy
Maria C. Pera et al.
BMC NEUROLOGY (2017)
Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
L. A. Nash et al.
CURRENT MOLECULAR MEDICINE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
Courtney L. Sutphen et al.
JAMA NEUROLOGY (2015)
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Ricarda A. L. Menke et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?
Monir Shababi et al.
JOURNAL OF ANATOMY (2014)
Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
Kevin B. Boylan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
pNfH is a promising biomarker for ALS
Jeban Ganesalingam et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Spinal Muscular Atrophy: A Clinical and Research Update
Jennifer A. Markowitz et al.
PEDIATRIC NEUROLOGY (2012)
Neurofilament heavy subunit in cerebrospinal fluid: A biomarker of amyotrophic lateral sclerosis?
Deise M. F. Mendonca et al.
AMYOTROPHIC LATERAL SCLEROSIS (2011)
Cerebrospinal fluid levels of S-100b protein and neuron-specific enolase in chronic inflammatory demyelinating polyneuropathy
M. Nagamatsu et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis
Cagla Eroglu et al.
CELL (2009)
CSF neurofilament protein analysis in the differential diagnosis of ALS
Thierry S. Reijn et al.
JOURNAL OF NEUROLOGY (2009)
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Arthur H. M. Burghes et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Performance characteristics of seven neuron-specific enolase assays
Petr Stern et al.
TUMOR BIOLOGY (2007)
Axonal damage markers in cerebrospinal fluid are increased in ALS
J Brettschneider et al.
NEUROLOGY (2006)
Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis
KS Christopherson et al.
CELL (2005)
CSF markers for Alzheimer's disease:: Total Tau, phospho-tau and Aβ42
N Andreasen et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2003)
S-100β protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury
PC Spinella et al.
CRITICAL CARE MEDICINE (2003)
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
C Hesse et al.
NEUROSCIENCE LETTERS (2001)
The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III
S Rudnik-Schoneborn et al.
EUROPEAN NEUROLOGY (2001)
分享论文
